TY - JOUR
T1 - Development of a platform for activatable fluorescent substrates of glucose transporters (GLUTs)
AU - Takasugi, Tomohiro
AU - Hanaoka, Kenjiro
AU - Sasaki, Ayako
AU - Ikeno, Takayuki
AU - Komatsu, Toru
AU - Ueno, Tasuku
AU - Yamada, Katsuya
AU - Urano, Yasuteru
N1 - Funding Information:
MIN6 cells were kindly provided by Dr. Junichi Miyazaki, Osaka University. This research was supported in part by the Ministry of Education, Culture, Sports, Science and Technology of Japan (JP16H05099 and JP18H04609 to K.H. and JP16H06574 to T.U.), SENTAN, JST to K.H, and Hirosaki University Institutional Grant to K.Y. K.H. was also supported by a grant JSPS Core-to-Core program, A. Advanced Research Networks.
Funding Information:
MIN6 cells were kindly provided by Dr. Junichi Miyazaki, Osaka University. This research was supported in part by the Ministry of Education, Culture, Sports, Science and Technology of Japan ( JP16H05099 and JP18H04609 to K.H., and JP16H06574 to T.U.), SENTAN , JST to K.H, and Hirosaki University Institutional Grant to K.Y. K.H. was also supported by a grant JSPS Core-to-Core program, A. Advanced Research Networks.
Publisher Copyright:
© 2019
PY - 2019/5/15
Y1 - 2019/5/15
N2 - We have developed a platform for activatable fluorescent substrates of glucose transporters (GLUTs). We firstly conjugated fluorescein to glucosamine via an amide or methylene linker at the C-2 position of D-glucosamine, but the resulting compounds, FLG1 and FLG2, showed no uptake into MIN6 cells. So, we changed the fluorophore moiety to a fluorescein analogue, 2-Me TokyoGreen, which is less negatively charged. TokyoGreen-conjugated glucosamines TGG1 and TGG2 were successfully taken up into cells via GLUT. We further derivatized TGG1 and TGG2, and among the synthesized compounds, 2-Me-4-OMe TGG showed weak fluorescence under the acidic conditions of the extracellular environment inside tumors and in gastric cancers, and strong fluorescence at the intracellular physiological pH, under the control of a photoinduced electron transfer (PeT) process. This fluorogenic platform should be useful for developing a range of activatable fluorescent substrates targeting GLUTs, as well as derivatives that would be fluorescently activated by various intracellular enzymes, such as esterases, β-galactosidase and bioreductases.
AB - We have developed a platform for activatable fluorescent substrates of glucose transporters (GLUTs). We firstly conjugated fluorescein to glucosamine via an amide or methylene linker at the C-2 position of D-glucosamine, but the resulting compounds, FLG1 and FLG2, showed no uptake into MIN6 cells. So, we changed the fluorophore moiety to a fluorescein analogue, 2-Me TokyoGreen, which is less negatively charged. TokyoGreen-conjugated glucosamines TGG1 and TGG2 were successfully taken up into cells via GLUT. We further derivatized TGG1 and TGG2, and among the synthesized compounds, 2-Me-4-OMe TGG showed weak fluorescence under the acidic conditions of the extracellular environment inside tumors and in gastric cancers, and strong fluorescence at the intracellular physiological pH, under the control of a photoinduced electron transfer (PeT) process. This fluorogenic platform should be useful for developing a range of activatable fluorescent substrates targeting GLUTs, as well as derivatives that would be fluorescently activated by various intracellular enzymes, such as esterases, β-galactosidase and bioreductases.
KW - Fluorescent imaging
KW - Fluorescent substrates
KW - GLUT
KW - Glucose
KW - Tumor
UR - http://www.scopus.com/inward/record.url?scp=85063471262&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85063471262&partnerID=8YFLogxK
U2 - 10.1016/j.bmc.2019.02.055
DO - 10.1016/j.bmc.2019.02.055
M3 - Article
C2 - 30935790
AN - SCOPUS:85063471262
VL - 27
SP - 2122
EP - 2126
JO - Bioorganic and Medicinal Chemistry
JF - Bioorganic and Medicinal Chemistry
SN - 0968-0896
IS - 10
ER -